Fremanezumab for preventing migraine (NICE TA764)
1.1 Fremanezumab is recommended as an option for preventing migraine in adults, only if:
they have 4 or more migraine days a month
at least 3 preventive drug treatments have failed and
the company provides it according to the commercial arrangement.